Explore comprehensive CDMO services offered by Catalent Inc, supporting end-to-end Anlaytical Testing, Drug Development, Manufacturing and Packaging. Catalent Inc enables faster, compliant, and scalable pharma innovation tailored to your needs.
Country: Argentina, Australia, Belgium, Brazil, Canada, Chile, China, Czech Republic, Denmark, Egypt, Finland, France, Gautemala, Germany, India, Indonesia, Israel, Italy, Japan, Malaysia, Norway, Peru, Russia, Singapore, South Africa, South Korea, Spain, Sweden, Taiwan, Thailand, Turkey, U.S.A.
Description: Catalent is a leading global contract development and manufacturing organization (CDMO) known for its comprehensive pharmaceutical and biotech services, including drug development, advanced delivery technologies, and large-scale manufacturing for a wide range of products. The company supports more than half of FDA-approved products in the last decade, annually producing around 70 billion doses for 8,000 products across 50+ facilities worldwide. It is headquartered in Somerset, New Jersey, and since December 2024, is a subsidiary of Novo Holdings A/S. The company is a critical partner for major pharmaceutical firms such as Bayer, Bristol-Myers Squibb, GlaxoSmithKline, Novo Nordisk, Moderna, and Pfizer, among others. Catalent's specialties span analytical chemistry, formulation development, biologics, cell and gene therapy, vaccine production, clinical packaging, and supply chain management. - Show More
